Home/Filings/4/0001127602-18-006414
4//SEC Filing

DiFabio Andrea 4

Accession 0001127602-18-006414

CIK 0001681689other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:59 PM ET

Size

8.2 KB

Accession

0001127602-18-006414

Insider Transaction Report

Form 4
Period: 2018-02-14
DiFabio Andrea
EVP, Chief Legal Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2018-02-143,7447,489 total
    Common Stock (3,744 underlying)
  • Tax Payment

    Common Stock

    2018-02-14$103.52/sh1,136$117,59933,338.558 total
  • Exercise/Conversion

    Common Stock

    2018-02-14+3,74434,474.558 total
Footnotes (3)
  • [F1]Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F3]The restricted stock units vest in three equal annual installments beginning on February 14, 2018.

Issuer

Bioverativ Inc.

CIK 0001681689

Entity typeother

Related Parties

1
  • filerCIK 0001692506

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:59 PM ET
Size
8.2 KB